Patents by Inventor Vidana Epa

Vidana Epa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fc receptor modulators and uses thereof
    Patent number: 7553809
    Abstract: This invention relates to a method of inhibiting Fc receptor binding of immunoglobulin including the use of a Fc receptor modulating compound which binds to defined surfaces on a Fc receptor. The present invention also relates to a method for treating a variety of diseases using a Fc receptor modulating compound.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: June 30, 2009
    Assignee: Ilexus Pty Limited
    Inventors: Jonathan B. Baell, Thomas P. J. Garrett, P. Mark Hogarth, Barry R. Matthews, Thomas D. McCarthy, Geoffrey A. Pietersz, Maree S. Powell, Ian F. C. McKenzie, Kelly F. Maxwell, Vidana Epa
  • Ecdysone receptor ligand-binding domain structure
    Publication number: 20070099232
    Abstract: The present invention relates to structural studies of the functional insect ecdysone receptor. More particularly, the invention relates to the crystal structure of the whitefly ecdysone receptor ligand-binding domain, specifically that of Bemisia tabaci, and uses of the crystal and related structural information to select and screen for compounds that interact with the receptor.
    Type: Application
    Filed: May 27, 2004
    Publication date: May 3, 2007
    Inventors: Michael Lawrence, Patricia Pilling, George Lovrecz, Vidana Epa, Jennifer Camichael, Leonie Noyce, Lloyd Graham, Garry Hannan, David Winkler, Ronald Hill
  • Fc receptor modulators and uses thereof
    Publication number: 20060057144
    Abstract: This invention relates to a method of inhibiting FC receptor binding of immunoglobulin comprising the use of a Fc receptor modulating compound which binds to defined surfaces on a Fc receptor. The present invention also relates to a method for treating a variety of diseases using a Fc receptor modulating compound.
    Type: Application
    Filed: June 3, 2004
    Publication date: March 16, 2006
    Inventors: Jonathan Baell, Thomas Garrett, P. Hogarth, Barry Matthews, Thomas McCarthy, Geoffrey Pietersz, Maree Powell, Ian McKenzie, Kelly Maxwell, Vidana Epa
  • Three dimensional structures and models of Fc receptors and uses thereof
    Publication number: 20040054480
    Abstract: Disclosed are crystals, crystal structure Fc&ggr;RIIa protein, three dimensional coordinates of Fc&ggr;RIIa protein, and structures and models derived from the Fc&ggr;RIIa structure. Also disclosed are crystals of Fc&egr;RI protein and three dimensional coordinates of Fc&egr;RI protein monomers and dimers derived from the Fc&ggr;RIIa structure. Also disclosed are three dimensional coordinates of Fc&ggr;RIIIb proteins and models of Fc&ggr;RIIIb derived from the Fc&ggr;RIIa structure. The present invention also includes methods to produce such crystals, crystal structures and models. Uses of such crystals, crystal structures and models are also disclosed, including structure based drug design and therapeutic compositions.
    Type: Application
    Filed: October 15, 2003
    Publication date: March 18, 2004
    Applicant: Ilexus Pty Limited
    Inventors: P. Mark Hogarth, Maree S. Powell, Ian F.C. McKenzie, Kelly F. Maxwell, Thomas P.J. Garrett, Vidana Epa
  • Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors
    Patent number: 6675105
    Abstract: Disclosed are crystals, crystal structure Fc&ggr;RIIa protein, three dimensional coordinates of Fc&ggr;RIIa protein, and structures and models derived from the Fc&ggr;RIIa structure. Also disclosed are crystals of Fc&egr;RI protein and three dimensional coordinates of Fc&egr;RI protein monomers and dimers derived from the Fc&ggr;RIIa structure. Also disclosed are three dimensional coordinates of Fc&ggr;RIIIb proteins and models of Fc&ggr;RIIIb derived from the Fc&ggr;RIIa structure. The present invention also includes methods to produce such crystals, crystal structures and models. Uses of such crystals, crystal structures and models are also disclosed, including structure based drug design and therapeutic compositions.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: January 6, 2004
    Assignee: Ilexus Pty Limited
    Inventors: P. Mark Hogarth, Maree S. Powell, Ian F. C. McKenzie, Kelly F. Maxwell, Thomas P. J. Garrett, Vidana Epa
  • THREE DIMENSIONAL STRUCTURES AND MODELS OF FC RECEPTORS AND USES THEREOF
    Publication number: 20020107359
    Abstract: Disclosed are crystals, crystal structure Fc&ggr;RIIa protein, three dimensional coordinates of Fc&ggr;RIIa protein, and structures and models derived from the Fc&ggr;RIIa structure. Also disclosed are crystals of Fc&egr;RI protein and three dimensional coordinates of Fc&egr;RI protein monomers and dimers derived from the Fc&ggr;RIIa structure. Also disclosed are three dimensional coordinates of Fc&ggr;RIIIb proteins and models of Fc&ggr;RIIIb derived from the Fc&ggr;RIIa structure. The present invention also includes methods to produce such crystals, crystal structures and models. Uses of such crystals, crystal structures and models are also disclosed, including structure based drug design and therapeutic compositions.
    Type: Application
    Filed: February 5, 1999
    Publication date: August 8, 2002
    Inventors: P. MARK HOGARTH, MAREE S. POWELL, IAN F.C. MCKENZIE, KELLY F. MAXWELL, THOMAS P.J. GARRETT, VIDANA EPA